{"id":"NCT01676220","sponsor":"Sanofi","briefTitle":"Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy","officialTitle":"6-Month, Multicenter, Randomized, Open-label, Parallel-group Study Comparing the Efficacy and Safety of a New Formulation of Insulin Glargine and Lantus® in Insulin-Naïve Patients With Type 2 Diabetes Mellitus Not Adequately Controlled With Non-Insulin Antihyperglycemic Drugs With a 6-month Safety Extension Period","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-08","primaryCompletion":"2013-09","completion":"2014-03","firstPosted":"2012-08-30","resultsPosted":"2015-04-23","lastUpdate":"2015-06-24"},"enrollment":878,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Type 2 Diabetes Mellitus"],"interventions":[{"type":"DRUG","name":"HOE901-U300 (new formulation of insulin glargine)","otherNames":[]},{"type":"DRUG","name":"Lantus (insulin glargine)","otherNames":["Lantus"]}],"arms":[{"label":"HOE901-U300","type":"EXPERIMENTAL"},{"label":"Lantus","type":"ACTIVE_COMPARATOR"}],"summary":"Primary Objective:\n\nTo compare the efficacy of a new formulation of insulin glargine and Lantus in terms of change of HbA1c from baseline to endpoint (scheduled at Month 6, Week 26) in participants with type 2 diabetes mellitus\n\nSecondary Objectives:\n\nTo compare a new formulation of insulin glargine and Lantus in terms of:\n\n\\- occurrence of nocturnal hypoglycemia","primaryOutcome":{"measure":"Change in HbA1c From Baseline to Month 6 Endpoint","timeFrame":"Baseline, Month 6","effectByArm":[{"arm":"HOE901-U300","deltaMin":-1.42,"sd":0.047},{"arm":"Lantus","deltaMin":-1.46,"sd":0.048}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":8},"locations":{"siteCount":217,"countries":["United States","Bulgaria","Canada","Czechia","Denmark","Estonia","Finland","Hungary","Japan","Latvia","Lithuania","Netherlands","Puerto Rico","Romania","Slovakia","Sweden"]},"refs":{"pmids":["25641260","30366067","30160030","29370218"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":35,"n":435},"commonTop":["Nasopharyngitis","Upper respiratory tract infection","Headache","Sinusitis"]}}